Aage Vølund

8.7k citations

75 papers · 6.7k indexed · 2 hit papers · h-index 34

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Treatment and Management
- Diabetes Management and Research
Endocrine and Autonomic Systems top 2%

Papers in

Endocrinology, Diabetes and Metabolism 39
- Diabetes Management and Research 26
- Diabetes Treatment and Management 13
Dermatology 10
- Contact Dermatitis and Allergies 7

Co-authors: Sten Madsbad Jens J. Holst Richard N. Bergman Jens Brange Allan Vaag Claus M. Larsen Marc Y. Donath Mirjam Faulenbach
Journals: Diabetes Care (8 papers)Diabetes (7 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)Contact Dermatitis (4 papers)Biometrics (4 papers)
Partner nations: Denmark United Kingdom United States

In The Last Decade

Aage Vølund

74 papers receiving 6.4k citations

Hit Papers

align trajectories log scale

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus 2007 · 1.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 New England Journal of Medicine
1987 Journal of Clinical Investigation

Peers

Countries citing papers authored by Aage Vølund

Since Specialization

Citations

This map shows the geographic impact of Aage Vølund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aage Vølund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aage Vølund more than expected).

Fields of papers citing papers by Aage Vølund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aage Vølund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aage Vølund. The network helps show where Aage Vølund may publish in the future.

Co-authors

The 25 scholars most cited alongside Aage Vølund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aage Vølund Line = papers co-authored together Aage Vølund links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Topical Calcineurin Inhibitors, Topical Glucocorticoids and Cancer in Children: A Nationwide Study Acta Dermato Venereologica ·Mette Deleuran, Christian Vestergaard, Aage Vølund, Kristian Thestrup‐Pedersen	2014	9
2	Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24‐h euglycaemic clamp studies in healthy humans Diabetic Medicine ·Lars Peter Sørensen, Birgitte Brock, A. Mengel, Jørgen Rungby, Niels Møller, Søren Nielsen, Aage Vølund, O. Schmitz	2010	11
3	Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes Diabetologia ·Patricia V. Højberg, Bruno Balduccini, Tina Vilsbøll, Filip K. Knop, Thure Krarup, Aage Vølund, Jens J. Holst, Sten Madsbad	2008	75
4	Patch test dose-response study: polysensitized individuals do not express lower elicitation thresholds than single/double-sensitized individuals British Journal of Dermatology ·Berit Christina Carlsen, Louise Arup Fischer, Heidi Søsted, Aage Vølund, Torkil Menné, Jeanne Duus Johansen	2008	3
5	K_ATPChannel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes The Journal of Clinical Endocrinology & Metabolism ·Kasper Aaboe, Filip K. Knop, Tina Vilsbøll, Aage Vølund, Ulf Simonsen, Carolyn F. Deacon, Sten Madsbad, Jens J. Holst, Thure Krarup	2008	44
6	Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus New England Journal of Medicine ·Claus M. Larsen, Mirjam Faulenbach, Allan Vaag, Aage Vølund, Jan A. Ehses, Burkhardt Seifert, Thomas Mandrup‐Poulsen, Marc Y. Donath Hit paper breakdown →	2007	1390
7	Bioequivalence of Topical Formulations in Humans: Evaluation by Dermal Microdialysis Sampling and the Dermatopharmacokinetic Method Journal of Investigative Dermatology ·Eva Benfeldt, Steen Honoré Hansen, Aage Vølund, Torkil Menné, Vinod P. Shah	2006	66
8	Within-patient variation of the pharmacokinetics of subcutaneously injected biphasic insulin aspart as assessed by compartmental modelling Diabetologia ·剑波, Andrea De Gaetano, Aage Vølund	2006	20
9	Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution American Journal of Physiology-Endocrinology and Metabolism ·Filip K. Knop, Tina Vilsbøll, Steen Larsen, Patricia V. Højberg, Aage Vølund, Sten Madsbad, Jens J. Holst, Thure Krarup	2006	94
10	Normal Secretion and Action of the Gut Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Young Men with Low Birth Weight The Journal of Clinical Endocrinology & Metabolism ·Bruna Brazeiro Brum, Kasper Pilgaard, Tina Vilsbøll, Christine B. Jensen, Carolyn F. Deacon, Jens J. Holst, Aage Vølund, Sten Madsbad, Allan Vaag	2005	20
11	In nondiabetic, human immunodeficiency virus–infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance Metabolism ·Steen B. Haugaard, Ove Andersen, Birgitte Rønde Hansen, Ulrik B. Andersen, Aage Vølund, Johan Iversen, Jens Nielsen, Sten Madsbad	2005	7
12	β‐Cell dysfunction and low insulin clearance in insulin‐resistant human immunodeficiency virus (HIV)‐infected patients with lipodystrophy Clinical Endocrinology ·Steen B. Haugaard, Ove Andersen, Aage Vølund, Birgitte Rønde Hansen, Johan Iversen, Ulrik B. Andersen, Jens Nielsen, Sten Madsbad	2005	17
13	Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes Metabolism ·Heidi Storgaard, Christine B. Jensen, Allan Vaag, Aage Vølund, Sten Madsbad	2003	44
14	Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in β-cell function Metabolism ·Ove Andersen, Steen B. Haugaard, Ulrik B. Andersen, Nina Friis‐Møller, Heidi Storgaard, Aage Vølund, Jens Nielsen, Johan Iversen, Sten Madsbad	2003	41
15	Combined effects of irritants and allergens Contact Dermatitis ·Tove Agner, Jeanne Duus Johansen, Timothy David King, Aage Vølund, David A. Basketter, Torkil Menné	2002	56
16	VALIDITY AND USE OF A NON-PARALLEL INSULIN ASSAY FOR PHARMACOKINETIC STUDIES OF THE RAPID-ACTING INSULIN ANALOGUE, INSULIN ASPART Journal of Immunoassay and Immunochemistry ·Lennart Andersen, Aage Vølund, 麻亜沙奥田, 亜純有谷, Declan Walsh	2001	8
17	The guinea pig maximization test--with a multiple dose design. Acta Dermato Venereologica ·K. E. Andersen, Aage Vølund, لیلا سعیدی ابواسحقی	1995	55
18	Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients. The Journal of Clinical Endocrinology & Metabolism ·Erik Christiansen, Annika Tibell, Aage Vølund, K Rasmussen, Gunnar Tydén, Oluf Pedersen, N. J. Christensen, Sten Madsbad	1994	13
19	Prehepaticβ-Cell Secretion During the Intravenous Glucose Tolerance Test in Humans: Application of a Combined Model of Insulin and C-Peptide Kinetics* The Journal of Clinical Endocrinology & Metabolism ·Jeanette Susana Mendoza Loli, Aage Vølund, Subir Roy, Richard N. Bergman	1989	60
20	Induction of formaldehyde contact sensitivity: dose response relationship in the guinea pig maximization test Acta Dermato Venereologica ·Andersen Ke, A Boman, Aage Vølund, Priya Thaivalappil Padmanabhan	1985	35

About Aage Vølund

Aage Vølund is a scholar working on Endocrinology, Diabetes and Metabolism, Dermatology, Transplantation, Emergency Medicine and Genetics, having authored 75 papers that have together received 6.7k indexed citations. Recurring topics across this work include Diabetes Management and Research (26 papers), Pancreatic function and diabetes (23 papers), Diabetes and associated disorders (20 papers), Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (10 papers), Contact Dermatitis and Allergies (7 papers), Analytical Chemistry and Chromatography (4 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Endocrine and Autonomic Systems (392 citations), Surgery (2.3k citations), Dermatology (381 citations) and Genetics (1.1k citations). Aage Vølund has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Sten Madsbad, Jens J. Holst, Richard N. Bergman, Jens Brange, Allan Vaag, Claus M. Larsen, Marc Y. Donath, Mirjam Faulenbach, Burkhardt Seifert and Jan A. Ehses. Their work appears in journals such as Diabetes Care, Diabetes, The Journal of Clinical Endocrinology & Metabolism, Contact Dermatitis and Biometrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact